Home
Hetero Biopharma

Hetero Biopharma Market Share Analysis for August 2026

Industry: N/A

Domainheterobiopharma.com

Year Founded2009

Employees1001 - 5000

Annual Revenue--

Hetero Biopharma

Hetero Biopharma (including company regionals)

heterobiopharma.com

See more website traffic and engagement information

Total visits to Hetero Biopharma's top domains

Understand Hetero Biopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

heterobiopharma.com1.2K

See more with Sales Intelligence

Avg. visit duration in Hetero Biopharma's top domains

Analyze Hetero Biopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

heterobiopharma.com00:01:08

See more with Sales Intelligence

Avg. pageviews on Hetero Biopharma's top domains

See how Hetero Biopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

heterobiopharma.com2.76

See more with Sales Intelligence

Hetero Biopharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Hetero Biopharma

These are the website technologies, by industry, used by Hetero Biopharma top domains

Widget (3)

Google Maps

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

Email Services (2)

GoDaddy Email

More Technologies

7

See all

News & Signals from Hetero Biopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRussian Direct Investment Fund partners with Hetero Biopharma Ltd.The Russian Direct Investment Fund (RDIF), promoters of the Sputnik V COVID-19 vaccine candidate , has entered into a deal with Hyderabad-based Hetero Biopharma, to manufacture over 100 million doses annually.